The invention relates to a vaccine composition comprising:a) inactivated whole virus, andb) a stabilizing excipient which comprises: i. a buffer solution,ii. a mixture of essential and nonessential amino acids,iii. a disaccharide,iv. a polyol,v. a chelating agent,vi. urea or a urea derivative, andvii. a nonionic surfactant.
